Release of prostacyclin into the bloodstream and its exhaustion in humans after local blood flow changes (ischemia and venous stasis).

No abstract is available for this paper.

• Publication year

  1980

• Venue

  Thrombosis Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0049-3848(80)90306-0PMID 6990547
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• COMPARISON OF THE VASODEPRESSOR EFFECTS OF PROSTACYCLIN AND 6‐OXO‐PROSTAGLANDIN F1α WITH THOSE OF PROSTAGLANDIN E2 IN RATS AND RABBITS

  1978cited by this paper
• Cardiac and renal prostaglandin I2. Biosynthesis and biological effects in isolated perfused rabbit tissues.

  1978cited by this paper
• The effects of prostacyclin (PGI2) on tissues which detect prostaglandins (PG'S).

  1977cited by this paper
• The effect of hypoxia on prostaglandin output and on tone in isolated coronary arteries.

  1977cited by this paper
• Cardiac prostaglandin release during myocardial ischemia induced by atrial pacing in patients with coronary artery disease.

  1977cited by this paper
• Prostacyclin (PGX) is the endogeneous metabolite responsible for relaxation of coronary arteries induced by arachidonic acid

  1977cited by this paper
• Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachindonic acid.

  1977cited by this paper
• Bioassay by cascade superfusion using a highly sensitive laminar flow technique

  1977cited by this paper
• Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium.

  1977cited by this paper
• Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation.

  1977cited by this paper
• The chemical structure of prostaglandin X (prostacyclin).

  1976cited by this paper
• An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

  1976cited by this paper
• A laminar flow superfusion technique with much increased sensitivity for the detection of smooth muscle-stimulating substances.

  1976cited by this paper
• Anoxia‐Induced Release of Prostaglandins in Rabbit Isolated Hearts

  1975cited by this paper
• Relationship between oxygen tension, coronary vasodilation and prostaglandin biosynthesis in the isolated rabbit heart.

  1975cited by this paper
• Hypoxia causes prostaglandin release from perfused rabbit hearts.

  1974cited by this paper
• Modification of basal release of prostaglandins from rabbit isolated hearts.

  1974cited by this paper
• Prostaglandin‐Like Substances Appearing in Canine Renal Venous Blood During Renal Ischemia: Their Partial Characterization By Pharmacologic And Chromatographic Procedures

  1970cited by this paper
• The release and fate of vaso‐active hormones in the circulation

  1969cited by this paper
• Blood flow in human muscles during external pressure or venous stasis.

  1967cited by this paper

• Measurement of platelet p-selectin expression by flow cytometry in patients with acute ischemic stroke

  2018cites this paper
• Thromboxane A2 and prostacyclin release in bleeding time blood during primary haemostasis in healthy individuals.

  2009cites this paper
• The effect of exercise on bleeding time and local production of prostacyclin and thromboxane

  2006cites this paper
• Resistance in Humans

  2005cites this paper
• Enhanced prostacyclin production by dipyridamole in man

  2004influential citation
• Elevated urinary levels of thromboxane and prostacyclin metabolites in sickle cell disease reflects activated platelets in the circulation

  1994cites this paper
• Effects of exercise training on the biosynthesis of prostacyclin and thromboxane in rats.

  1993cites this paper
• Repeated sympathetic stimuli elicit the decline and disappearance of prostaglandin modulation and an increase of vascular resistance in humans.

  1990cites this paper
• Regional Variability of Prostacyclin Biosynthesis

  1989cites this paper
• Inhibition of Tissue Plasminogen Activator Activity by Aspirin In Vivo and Its Relationship to Levels of Tissue Plasminogen Activator Antigen, Plasminogen Activator Inhibitor, and Their Complexes

  1989cites this paper
• Eicosanoid biosynthesis in human cardiovascular disease.

  1987cites this paper
• Low dose aspirin does not prevent fibrinolytic response to venous occlusion.

  1986cites this paper
• Prostacyclin production in regions of arterial stenosis.

  1985cites this paper
• Lack of efficacy of nafazatrom, a novel anti-thrombotic compound, in patients with coronary artery disease.

  1985cites this paper
• Aspirin, indomethacin and dazoxiben do not affect the fibrinolytic activation induced by venous occlusion.

  1985cites this paper
• Fat embolism and osteonecrosis.

  1985cites this paper
• Platelet and vessel wall prostaglandins in patients with sickle cell disease

  1985cites this paper
• The effects of intravenous insulin infusion on skin microcirculatory flow in Type 1 diabetes.

  1985cites this paper
• Lack of efficacy of nafaxatrom, a novel anti-thrombotic compound, in patients with coronary artery disease

  1985cites this paper
• Aspirin inhibits vascular plasminogen activator activity in vivo. Studies utilizing a new assay to quantify plasminogen activator activity.

  1984cites this paper
• Biology of Endothelial Cells

  1984cites this paper
• Role of prostacyclin and thromboxane A2 in ischaemic heart disease.

  1984cites this paper
• Prostacyclin production by endothelial cells

  1984cites this paper
• Vascular and platelet effects of prostacyclin and prostaglandin D 2 in man

  1984cites this paper
• Chapter 3 The prostacyclins

  1983cites this paper
• The significance of platelet-vessel wall prostaglandin equilibrium during exercise-induced stress☆

  1983cites this paper
• Venous thrombosis produced by the local injection of fat.

  1983cites this paper
• Increased plasma concentrations of prostacyclin metabolite 6-keto-PGF1α in essential hypertension

  1983cites this paper
• Role of PGE2 in the modulation of the adrenergic response in man.

  1983cites this paper
• [Effect of prostacyclin on erythrocyte deformability and blood viscosity].

  1983cites this paper
• Effects of prostaglandin E2 inhibition on norepinephrine plasma levels after adrenergic stimulation in man.

  1983cites this paper
• Increased plasma concentrations of prostacyclin metabolite 6-keto-PGF1 alpha in essential hypertension. Influence of therapy with labetalol.

  1983cites this paper
• EIGHTH GADDUM MEMORIAL LECTURE UNIVERSITY OF LONDON INSTITUTE OF EDUCATION DECEMBER 1980: BIOLOGICAL IMPORTANCE OF PROSTACYCLIN

  1982cites this paper
• Prostacyclin and 51Cr release in cultured human endothelial cells.

  1982cites this paper
• Prostacyclin: its biosynthesis, actions, and clinical potential.

  1982cites this paper
• Aspirin, prostacyclin and post-occlusive reactive hyperaemia in man.

  1982cites this paper
• The significance of platelet-vessel wall prostaglandin equilibrium during exercise-induced stress.

  1982cites this paper
• Prostacyclin and Its Therapeutic Potential

  1982cites this paper
• Prostacyclin in physiology and pathophysiology.

  1982cites this paper
• Prostacyclin is not a circulating hormone in man.

  1982cites this paper
• Altered arachidonic acid metabolism in platelets and in vessel wall in patients with ischaemic heart disease

  1982cites this paper
• Prostacyclin.

  1982cites this paper
• Prostacyclin: a hormone with a therapeutic potential. The Sir Henry Dale Lecture for 1981.

  1982cites this paper
• Effects of smoking on platelets and on plasma thromboxane-prostacyclin balance in man.

  1982cites this paper
• Reduced prostacyclin production in patients with different manifestations of ischemic heart disease.

  1982cites this paper
• Prostacyclin: its biosynthesis, actions and clinical potential.

  1981cites this paper
• Prostacyclin and the vascular endothelium.

  1981cites this paper
• Prostacyclin: its biosynthesis, actions and clinical potential.

  1981cites this paper
• Postischaemic hyperaemia studied with a transcutaneous oxygen electrode used at 33-37 degrees C.

  1981cites this paper
• Pathophysiological aspects of platelet aggregation in relation to blood flow rheology in microcirculation.

  1981cites this paper
• Postischaemic hyperaemia studied with a transcutaneous oxygen electrode used at 33—37°C

  1981cites this paper
• Prostacyclin and thromboxane A2 formation in response to adrenergic stimulation in humans: a mechanism for local control of vascular response to sympathetic activation?

  1981cites this paper